Live News Categoriesequity

Egetis Therapeutics AB (publ) (EGTX.ST) News

Track canonical SquawkNews coverage tagged to EGTX.ST, Egetis Therapeutics AB (publ). This hub brings together deduplicated headlines about stockholm, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol EGTX.ST Asset equity Sector Markets 90 days 1 Last 8.97 Updated Sep 29, 2026, 09:32 AM UTC Open live news feed

M Egetis shares jump about 13% after US FDA approval of Emcitate Rare disease drugmaker Egetis surged about 13% after US FDA approval of its Emcitate drug, with Van Lanschot Kempen saying the approval unlocks the firm’s largest opportunity and pointing to uptake expectations and comme EARNINGS | Sep 29, 2026, 09:32 AM UTC